EuroEspes Overview

  • Founded
  • 1991
  • Status
  • Public
  • Employees
  • 34
  • Stock Symbol
  • EEP
Stock Symbol
  • Investments
  • 2
  • Share Price
  • $0.53
  • (As of Monday Closing)

EuroEspes General Information


Euroespes SA is a biomedical research center offering medical, research, medical informatics and bioinformatics services. It offers medicine and personalized treatment for central nervous system disorders and researches genomic medicine. Other services offered by the company include genomics, digital diagnosis, diagnostic imaging, neuro-psychology, neuro-ophthalmology, nursing, epigenetics, clinical analysis and otorhinolaryngology.

Contact Information

Ownership Status
Publicly Held
Financing Status
Primary Industry
Other Industries
Drug Delivery
Drug Discovery
Stock Exchange
Primary Office
  • Santa Marta de Babío Bergondo
  • 15165 A Coruña
  • Spain
+34 981 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

EuroEspes Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.53 $0.55 $0.45 - $0.74 $6.17M 11.6M 13.8K -$0.04

EuroEspes Financials Summary

In Thousands,
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 6,918 6,918 7,993 9,489
Revenue 2,877 2,877 2,658 3,007
EBITDA 262 262 (271) 130
Net Income (469) (469) (1,409) (300)
Total Assets 14,388 14,388 12,740 14,596
Total Debt 4,485 4,485 3,731 3,863
Public Fundamental Data provided by Morningstar, Inc. disclaimer

EuroEspes Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore EuroEspes‘s full profile, request access.

Request a free trial

EuroEspes Executive Team (4)

Name Title Board Seat Contact Info
Ramon Cacabelos Garcia President
Javier Lopez Director Financiero
You’re viewing 2 of 4 executive team members. Get the full list »

EuroEspes Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EuroEspes Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore EuroEspes‘s full profile, request access.

Request a free trial

EuroEspes Investments & Acquisitions (2)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 00000000 01-Aug-2014 000000000000000000 Other Pharmaceuticals and Biotechnology
EuroEspes Biotecnología Corporate Other Pharmaceuticals and Biotechnology
To view EuroEspes’s complete investments and acquisitions history, request access »